674 related articles for article (PubMed ID: 17544525)
21. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
[TBL] [Abstract][Full Text] [Related]
22. Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome.
Kubler P; Jankowska EA; Majda J; Reczuch K; Banasiak W; Ponikowski P
Int J Cardiol; 2008 Oct; 129(3):373-8. PubMed ID: 18054808
[TBL] [Abstract][Full Text] [Related]
23. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
Tang WH; Steinhubl SR; Van Lente F; Brennan D; McErlean E; Maroo A; Francis GS; Topol EJ
Am Heart J; 2007 Jan; 153(1):36-41. PubMed ID: 17174634
[TBL] [Abstract][Full Text] [Related]
24. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
25. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
[TBL] [Abstract][Full Text] [Related]
26. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
27. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
[TBL] [Abstract][Full Text] [Related]
28. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
[TBL] [Abstract][Full Text] [Related]
29. Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease.
Rothenbacher D; Koenig W; Brenner H
Arch Intern Med; 2006 Dec 11-25; 166(22):2455-60. PubMed ID: 17159010
[TBL] [Abstract][Full Text] [Related]
30. Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?
Timóteo AT; Toste A; Ramos R; Miranda F; Ferreira ML; Oliveira JA; Ferreira RC
Acute Card Care; 2009; 11(4):236-42. PubMed ID: 19742352
[TBL] [Abstract][Full Text] [Related]
31. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock.
Varpula M; Pulkki K; Karlsson S; Ruokonen E; Pettilä V;
Crit Care Med; 2007 May; 35(5):1277-83. PubMed ID: 17414731
[TBL] [Abstract][Full Text] [Related]
33. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
34. The value of NT-proBNP in early risk stratification of acute coronary syndromes.
Almeida R; Mariano L; Gavina C; Pinho T; Vasconcelos M; Ferreira A; Maciel MJ; Gonçalves FR
Rev Port Cardiol; 2006 Jan; 25(1):71-5. PubMed ID: 16623357
[TBL] [Abstract][Full Text] [Related]
35. N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus.
Farombi-Oghuvbu I; Matthews T; Mayne PD; Guerin H; Corcoran JD
Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F257-60. PubMed ID: 18218660
[TBL] [Abstract][Full Text] [Related]
36. N-Terminal pro B-type natriuretic peptide testing for short-term prognosis in breathless older adults.
Chenevier-Gobeaux C; Allo JC; Arthaud M; Achkar R; Claessens YE; Ekindjian OG; Riou B; Ray P
Am J Emerg Med; 2008 Jun; 26(5):555-60. PubMed ID: 18534284
[TBL] [Abstract][Full Text] [Related]
37. Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
Walter T; Brueckmann M; Lang S; Sauer T; Fiedler E; Papassotiriou J; Behnes M; Elmas E; Borggrefe M; Bertsch T
Clin Lab; 2010; 56(7-8):303-9. PubMed ID: 20857894
[TBL] [Abstract][Full Text] [Related]
38. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
Joung B; Ha JW; Ko YG; Kang SM; Rim SJ; Jang Y; Chung N; Shim WH; Cho SY
Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
[TBL] [Abstract][Full Text] [Related]
39. Obese and nonobese patients with essential hypertension show similar N-terminal proBNP plasma levels.
Cortés R; Otero MR; Morillas P; Roselló-Lletí E; Grigorian L; Martínez-Dolz L; de Burgos FG; Calabuig JR; Soria F; Lozano T; Portolés M; Bertomeu V
Am J Hypertens; 2008 Jul; 21(7):820-5. PubMed ID: 18443568
[TBL] [Abstract][Full Text] [Related]
40. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
Hess G; Runkel S; Zdunek D; Hitzler WE
Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
